Aranake-Chrisinger J, Dassopoulos T, Yan Y, Nalbantoglu I. Primary sclerosing cholangitis associated colitis: Characterization of clinical, histologic features, and their associations with liver transplantation. World J Gastroenterol 2020; 26(28): 4126-4139 [PMID: 32821074 DOI: 10.3748/wjg.v26.i28.4126]
Corresponding Author of This Article
ILKe Nalbantoglu, MD, Associate Professor, Physician, Department of Pathology, Yale University School of Medicine, 20 York Street, EP2-608B, New Haven, CT 06510, United States. ilke.nalbantoglu@yale.edu
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Jul 28, 2020; 26(28): 4126-4139 Published online Jul 28, 2020. doi: 10.3748/wjg.v26.i28.4126
Primary sclerosing cholangitis associated colitis: Characterization of clinical, histologic features, and their associations with liver transplantation
John Aranake-Chrisinger, Themistocles Dassopoulos, Yan Yan, ILKe Nalbantoglu
John Aranake-Chrisinger, ILKe Nalbantoglu, Department of Pathology and Immunology, Lauren V. Ackerman Laboratory of Surgical Pathology, Washington University in St. Louis, School of Medicine, MO 63110, United States
Themistocles Dassopoulos, Baylor Center for IBD, Baylor University Medical Center, Dallas, TX 75246, United States
Yan Yan, Departments of Surgery and Biostatistics, Washington University in St. Louis, School of Medicine, MO 63110, United States
ILKe Nalbantoglu, Department of Anatomic Pathology, Yale University School of Medicine, New Haven, CT 06525, United States
Author contributions: Aranake-Chrisinger J, Nalbantoglu I, and Dassopoulos T came up with the study design; Aranake-Chrisinger J and Nalbantoglu I collected data and organized the manuscript; Yan Y performed the statistical analysis.
Institutional review board statement: This study was reviewed and approved by the Washington University in St. Louis, School of Medicine.
Informed consent statement: The subjects in this study were not required to give informed consent due to retrospective nature of the study and utilization of anonymous data utilization.
Conflict-of-interest statement: We have no financial relationships to disclose.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: ILKe Nalbantoglu, MD, Associate Professor, Physician, Department of Pathology, Yale University School of Medicine, 20 York Street, EP2-608B, New Haven, CT 06510, United States. ilke.nalbantoglu@yale.edu
Received: March 30, 2020 Peer-review started: March 30, 2020 First decision: April 25, 2020 Revised: June 8, 2020 Accepted: July 15, 2020 Article in press: July 15, 2020 Published online: July 28, 2020 Processing time: 119 Days and 21.5 Hours
Core Tip
Core tip: This is a retrospective study evaluating biopsies and clinical features of primary sclerosing cholangitis (PSC) patients with and without inflammatory bowel disease (IBD) in comparison to subjects with ulcerative colitis (UC) or Crohn disease (CD). Patients with PSC-UC had a different disease distribution characterized by right sided colitis, a milder disease course with lower activity scores in biopsies, less need for colectomy, and less steroids compared to UC. PSC-CD patients were rare but had more ileal inflammation compared to PSC-UC. PSC-No IBD patients showed similar characteristics to PSC patients in general and only one patient received orthotopic liver transplantation (OLT) in this group. Ten PSC-UC patients received OLT in contrast to no patients with PSC-CD. The need for OLT in PSC-IBD (PSC-UC and PSC-CD) correlated with rectal involvement and higher activity scores in the left colon biopsies in comparison to patients without OLT. This may require clinical attention since the both the intestinal and liver disease seem to be “severe” in this group further supporting the importance of gut-liver interaction in these patients.
